I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Adjuvant pembrolizumab versus placebo in resected high-risk..:
Khattak, Muhammad A
;
Luke, Jason J
;
Long, Georgina V
...
http://hdl.handle.net/10668/22180. , 2022
Link:
http://hdl.handle.net/10668/22180
RT Journal T1
Adjuvant pembrolizumab versus placebo in resected high-risk stage II melanoma: Health-related quality of life from the randomized phase 3 KEYNOTE-716 study
UL https://suche.suub.uni-bremen.de/peid=base-ftsspa:oai:www.repositoriosalud.es:10668_22180&Exemplar=1&LAN=DE A1 Khattak, Muhammad A A1 Luke, Jason J A1 Long, Georgina V A1 Ascierto, Paolo A A1 Rutkowski, Piotr A1 Schadendorf, Dirk A1 Robert, Caroline A1 Grob, Jean-Jacques A1 de la Cruz Merino, Luis A1 Del Vecchio, Michele A1 Spagnolo, Francesco A1 Mackiewicz, Jacek A1 Chiarion-Sileni, Vanna A1 Carlino, Matteo S A1 Mohr, Peter A1 De Galitiis, Federica A1 Ross, Merrick I A1 Eroglu, Zeynep A1 Chen, Ke A1 Jiang, Ruixuan A1 Fukunaga-Kalabis, Mizuho A1 Krepler, Clemens A1 Eggermont, Alexander M M A1 Kirkwood, John M YR 2022 K1 Adjuvant K1 Immunotherapy K1 Melanoma K1 Patient-reported outcomes K1 Pembrolizumab K1 Humans K1 Quality of Life K1 Neoplasm Recurrence K1 Local K1 Adjuvants K1 Immunologic JF http://hdl.handle.net/10668/22180 LK http://hdl.handle.net/10668/22180 DO http://hdl.handle.net/10668/22180 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)